Copyright Reports & Markets. All rights reserved.

Global Therapies and Diagnostics for Ovarian Cancer Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Therapies and Diagnostics for Ovarian Cancer Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Surgery
      • 1.4.3 Radiation Therapy
      • 1.4.4 Drug Treatment
    • 1.5 Market by Application
      • 1.5.1 Global Therapies and Diagnostics for Ovarian Cancer Market Share by Application (2019-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Therapies and Diagnostics for Ovarian Cancer Market Size
    • 2.2 Therapies and Diagnostics for Ovarian Cancer Growth Trends by Regions
      • 2.2.1 Therapies and Diagnostics for Ovarian Cancer Market Size by Regions (2019-2025)
      • 2.2.2 Therapies and Diagnostics for Ovarian Cancer Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Therapies and Diagnostics for Ovarian Cancer Market Size by by Players
      • 3.1.1 Global Therapies and Diagnostics for Ovarian Cancer Revenue by by Players (2014-2019)
      • 3.1.2 Global Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Therapies and Diagnostics for Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
    • 3.2 Therapies and Diagnostics for Ovarian Cancer Key Players Head office and Area Served
    • 3.3 Key Players Therapies and Diagnostics for Ovarian Cancer Product/Solution/Service
    • 3.4 Date of Enter into Therapies and Diagnostics for Ovarian Cancer Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Therapies and Diagnostics for Ovarian Cancer Market Size by Type (2014-2019)
    • 4.2 Global Therapies and Diagnostics for Ovarian Cancer Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Therapies and Diagnostics for Ovarian Cancer Market Size (2014-2019)
    • 5.2 Therapies and Diagnostics for Ovarian Cancer Key Players in North America
    • 5.3 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Type
    • 5.4 North America Therapies and Diagnostics for Ovarian Cancer Market Size by Application

    6 Europe

    • 6.1 Europe Therapies and Diagnostics for Ovarian Cancer Market Size (2014-2019)
    • 6.2 Therapies and Diagnostics for Ovarian Cancer Key Players in Europe
    • 6.3 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Type
    • 6.4 Europe Therapies and Diagnostics for Ovarian Cancer Market Size by Application

    7 China

    • 7.1 China Therapies and Diagnostics for Ovarian Cancer Market Size (2014-2019)
    • 7.2 Therapies and Diagnostics for Ovarian Cancer Key Players in China
    • 7.3 China Therapies and Diagnostics for Ovarian Cancer Market Size by Type
    • 7.4 China Therapies and Diagnostics for Ovarian Cancer Market Size by Application

    8 Japan

    • 8.1 Japan Therapies and Diagnostics for Ovarian Cancer Market Size (2014-2019)
    • 8.2 Therapies and Diagnostics for Ovarian Cancer Key Players in Japan
    • 8.3 Japan Therapies and Diagnostics for Ovarian Cancer Market Size by Type
    • 8.4 Japan Therapies and Diagnostics for Ovarian Cancer Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Therapies and Diagnostics for Ovarian Cancer Market Size (2014-2019)
    • 9.2 Therapies and Diagnostics for Ovarian Cancer Key Players in Southeast Asia
    • 9.3 Southeast Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Type
    • 9.4 Southeast Asia Therapies and Diagnostics for Ovarian Cancer Market Size by Application

    10 India

    • 10.1 India Therapies and Diagnostics for Ovarian Cancer Market Size (2014-2019)
    • 10.2 Therapies and Diagnostics for Ovarian Cancer Key Players in India
    • 10.3 India Therapies and Diagnostics for Ovarian Cancer Market Size by Type
    • 10.4 India Therapies and Diagnostics for Ovarian Cancer Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Therapies and Diagnostics for Ovarian Cancer Market Size (2014-2019)
    • 11.2 Therapies and Diagnostics for Ovarian Cancer Key Players in Central & South America
    • 11.3 Central & South America Therapies and Diagnostics for Ovarian Cancer Market Size by Type
    • 11.4 Central & South America Therapies and Diagnostics for Ovarian Cancer Market Size by Application

    12 International Players Profiles

    • 12.1 Astra Zeneca
      • 12.1.1 Astra Zeneca Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Therapies and Diagnostics for Ovarian Cancer Introduction
      • 12.1.4 Astra Zeneca Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019))
      • 12.1.5 Astra Zeneca Recent Development
    • 12.2 Clovis Oncology
      • 12.2.1 Clovis Oncology Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Therapies and Diagnostics for Ovarian Cancer Introduction
      • 12.2.4 Clovis Oncology Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
      • 12.2.5 Clovis Oncology Recent Development
    • 12.3 Myriad
      • 12.3.1 Myriad Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Therapies and Diagnostics for Ovarian Cancer Introduction
      • 12.3.4 Myriad Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
      • 12.3.5 Myriad Recent Development
    • 12.4 TESARO
      • 12.4.1 TESARO Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Therapies and Diagnostics for Ovarian Cancer Introduction
      • 12.4.4 TESARO Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
      • 12.4.5 TESARO Recent Development
    • 12.5 AbbVie Inc
      • 12.5.1 AbbVie Inc Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Therapies and Diagnostics for Ovarian Cancer Introduction
      • 12.5.4 AbbVie Inc Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
      • 12.5.5 AbbVie Inc Recent Development
    • 12.6 Celgene
      • 12.6.1 Celgene Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Therapies and Diagnostics for Ovarian Cancer Introduction
      • 12.6.4 Celgene Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
      • 12.6.5 Celgene Recent Development
    • 12.7 Janssen Pharmaceuticals
      • 12.7.1 Janssen Pharmaceuticals Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Therapies and Diagnostics for Ovarian Cancer Introduction
      • 12.7.4 Janssen Pharmaceuticals Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
      • 12.7.5 Janssen Pharmaceuticals Recent Development
    • 12.8 Merck
      • 12.8.1 Merck Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Therapies and Diagnostics for Ovarian Cancer Introduction
      • 12.8.4 Merck Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
      • 12.8.5 Merck Recent Development
    • 12.9 Novartis AG
      • 12.9.1 Novartis AG Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Therapies and Diagnostics for Ovarian Cancer Introduction
      • 12.9.4 Novartis AG Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
      • 12.9.5 Novartis AG Recent Development
    • 12.10 Quest Diagnostics Inc
      • 12.10.1 Quest Diagnostics Inc Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Therapies and Diagnostics for Ovarian Cancer Introduction
      • 12.10.4 Quest Diagnostics Inc Revenue in Therapies and Diagnostics for Ovarian Cancer Business (2014-2019)
      • 12.10.5 Quest Diagnostics Inc Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Ovarian cancer (ovarian cancer) accounts for 2.4% ~ 6.5% of the common malignant tumors in women, and ranks the third among the cancers of the female reproductive system, secondary to cervical cancer and uterine body cancer.In recent years, due to the prevention and treatment of cervical cancer and uterine body cancer, some achievements have been made, while the prevention and treatment of ovarian cancer is relatively small.So ovarian cancer is the leading cause of death among cancers of the reproductive system in women.
      In 2018, the global Therapies and Diagnostics for Ovarian Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Therapies and Diagnostics for Ovarian Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Therapies and Diagnostics for Ovarian Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Astra Zeneca
      Clovis Oncology
      Myriad
      TESARO
      AbbVie Inc
      Celgene
      Janssen Pharmaceuticals
      Merck
      Novartis AG
      Quest Diagnostics Inc

      Market segment by Type, the product can be split into
      Surgery
      Radiation Therapy
      Drug Treatment

      Market segment by Application, split into
      Hospitals
      Clinics
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Therapies and Diagnostics for Ovarian Cancer status, future forecast, growth opportunity, key market and key players.
      To present the Therapies and Diagnostics for Ovarian Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Therapies and Diagnostics for Ovarian Cancer are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now